Von Willebrand disease, type 2
ICD-10 D68.02 is a billable code used to indicate a diagnosis of von willebrand disease, type 2.
Von Willebrand disease (VWD) is a hereditary bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor (VWF), a protein essential for blood clotting. Type 2 VWD is characterized by a qualitative defect in VWF, leading to ineffective platelet adhesion and aggregation. Patients with type 2 VWD may experience symptoms such as easy bruising, prolonged bleeding from cuts, heavy menstrual periods, and spontaneous bleeding episodes. The severity of bleeding can vary widely among individuals, often correlating with the specific subtype of type 2 VWD. Diagnosis typically involves laboratory tests that assess VWF levels and function, including VWF antigen, VWF activity, and factor VIII levels. Management may include desmopressin (DDAVP) to stimulate the release of VWF from endothelial cells, along with factor replacement therapy in more severe cases. Understanding the nuances of this condition is crucial for effective treatment and management of bleeding risks.
Detailed documentation of bleeding history, laboratory results, and treatment plans.
Patients presenting with unexplained bleeding, family history of bleeding disorders, or abnormal laboratory findings.
Ensure accurate coding of the specific subtype of VWD and associated treatments.
Documentation of genetic testing results and family pedigree.
Patients with a family history of bleeding disorders seeking genetic counseling.
Documenting the inheritance pattern and implications for family members.
Used to confirm diagnosis of VWD.
Document the reason for testing and results.
Hematology specialists should ensure comprehensive lab results are included.
Type 1 is characterized by a quantitative deficiency of von Willebrand factor, while type 2 involves a qualitative defect affecting the function of the factor, leading to more severe bleeding symptoms.
